Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
PEPTONIC MEDICAL Aktie jetzt für 0€ handeln | |||||
10.09. | PEPTONIC MEDICAL AB: Peptonic Medical requests extension of corporate reconstruction and provides update on financial performance | 1 | Cision News | ||
26.08. | Peptonic Medical AB: Anna Linton resigns as CEO | 2 | Cision News | ||
26.06. | Bulletin from the annual general meeting in PEPTONIC medical AB | 1 | Cision News | ||
19.06. | PEPTONIC medical AB presents proposals for board members ahead of the annual general meeting on 26 June 2025 | 2 | Cision News | ||
17.06. | PEPTONIC MEDICAL AB: Peptonic Medical's request for extension of company reconstruction approved by Uppsala District Court | 1 | Cision News | ||
08.06. | PEPTONIC MEDICAL AB: Peptonic Medical: Request for extension of company reconstruction and update on the reconstruction process | 1 | Cision News | ||
08.06. | PEPTONIC MEDICAL AB: Correction: Peptonic Medical's Annual Report 2024 published | 4 | Cision News | ||
05.06. | PEPTONIC MEDICAL AB: Peptonic Medical's Annual Report 2024 published | 1 | Cision News | ||
05.06. | PEPTONIC Medical AB: Intends to submit a request for extension of ongoing corporate restructuring | 1 | Cision News | ||
23.05. | NOTICE TO THE ANNUAL GENERAL MEETING IN PEPTONIC MEDICAL AB | 2 | Cision News | ||
13.05. | PEPTONIC medical AB: Correction of the press release published on 7 May 2025 regarding resolution from the extraordinary general meeting on 7 January 2025 | 1 | Cision News | ||
07.05. | PEPTONIC Medical AB: Update regarding the resolution from the extraordinary general meeting on 7 January 2025 regarding the reduction of share capital and reverse share split | 1 | Cision News | ||
05.05. | PEPTONIC MEDICAL AB: Peptonic Medical changes date for publication of interim report Q1 2025 | 1 | Cision News | ||
28.04. | Spotlight Stock Market: Market Notice 74/25 - Last day of trading in PEPTONIC Medical AB's BTU | 1 | Cision News | ||
28.04. | PEPTONIC MEDICAL AB: Peptonic announces the last day of trading in BTU | 1 | Cision News | ||
04.04. | PEPTONIC Medical AB: Update due to ongoing corporate restructuring | 1 | Cision News | ||
04.04. | PEPTONIC MEDICAL AB: Peptonic Medical establishes subsidiary in the US with responsibility for direct sales | 2 | Cision News | ||
07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2025 | 374 | Xetra Newsboard | Das Instrument 0HC0 CA6083842022 MOJAVE BRANDS INC. EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2025 und ex Kapitalmassnahme am 08.01.2025 The instrument 0HC0 CA6083842022 MOJAVE BRANDS INC.... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 43,595 | +0,43 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für FMC von 40 auf 36 Euro gesenkt und die Einstufung auf "Underperform" belassen. Nach dem Kapitalmarkttag und den Quartalszahlen... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,710 | +0,95 % | Kursphantasien steigen - AJN Resources, HOCHTIEF, Siemens Healthineers | Nach den Kursrücksetzern der US-Börsen Anfang September notieren diese bereits wieder am Allzeithoch bzw. haben - wie der S & P 500 - bereits mit gestrigem Tage neue Allzeithochs erreichen können. Dagegen... ► Artikel lesen | |
FRESENIUS | 47,620 | +0,25 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Fresenius auf "Overweight" belassen. Die Aktie steht zudem auf der "Analyst Focus List" der US-Bank. Die Aktienkurse der europäischen Medizinunternehmen... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 27,400 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
UNITEDHEALTH | 291,80 | +1,00 % | Dividendenbekanntmachungen (15.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2954 EUR ALLEGION PLC IE00BFRT3W74 0,51 USD 0,4345 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
KINDLY MD | 1,425 | 0,00 % | Nigeria: Makurdi-Naka Road in Ruins As Residents Lament Insecurity, Poor State of Route | ||
ALIGNMENT HEALTHCARE | 16,685 | 0,00 % | Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics | Reports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics:... ► Artikel lesen | |
GERRESHEIMER | 43,640 | +0,79 % | GERRESHEIMER wird zunächst zur Spielwiese | Die Kurskorrektur ist massiv ausgefallen. Mit der Übernahme von Bormioli Pharma ist GERRESHEIMER angreifbar geworden, weil der Kaufpreis umfangreich fremdfinanziert wurde. Was rechnen sich die Investoren... ► Artikel lesen | |
CARL ZEISS MEDITEC | 44,820 | +1,68 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec auf "Underweight" belassen. Die Aktienkurse der europäischen Medizinunternehmen hätten sich seit Jahresbeginn überwiegend mau... ► Artikel lesen | |
QUIPT HOME MEDICAL | 2,680 | 0,00 % | Quipt Home Medical Corp: Quipt holder/suitor Forager highlights premium in offer | ||
MIMEDX | 6,940 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results | Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06... ► Artikel lesen | |
GENEDX | 127,76 | 0,00 % | Assessing GeneDx Holdings: Insights From 5 Financial Analysts | ||
ECKERT & ZIEGLER | 17,980 | +1,93 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat Eckert & Ziegler von "Hold" auf "Buy" hochgestuft, aber das Kursziel auf 21,70 Euro belassen. Alexander Galitsa verwies in einer am... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 37,300 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PROGYNY | 21,610 | 0,00 % | Progyny, Inc. Announces Second Quarter 2025 Results | Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance... ► Artikel lesen |